FHTX

NASD Foghorn Therapeutics, Inc.
Oct 14, 2026 · 7:25 AM ET LAST TRADE Market Closed

$1.92 ↑ +0.07 (+3.78%) Trading Up from the previous close of $1.85

YTD change
-64.44%
vs 20-day SMA
-37.33%
vs 200-day SMA
-61.09%

Price ranges

Previous day
$1.84 $1.95
open $1.91 close $1.85
-$0.06 (-3.14%)
Today
$0.00 $0.00
$1.92
Past week
$1.84 $2.15
from $1.97 now $1.92
-$0.05 (-2.54%)
Past month
$1.79 $4.32
from $4.12 now $1.92
-$2.20 (-53.40%)
This year
$1.79 $7.61
from $5.40 now $1.92
-$3.48 (-64.44%)

Price & Performance

-3.00 (-61.86%) / 6M

$1.43$3.45$5.47$7.49Apr 14Jul 15Oct 13

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 93.2% away from all-time highs of $28.27
  • FHTX is down 64% since the beginning of the year
  • FHTX is down 56% over the past 12 months
  • FHTX is down 53% over the past 1 month
  • 5% of all FHTX investors are betting against FHTX

FHTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -57.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.1
Earnings momentum +59.7% Quarterly EPS growth
Quarterly change +59.7%

Valuation

P/E ratio N/A
Enterprise value $6.2M
Beta 3.46

Balance sheet & scale

IncomeN/A
Revenue$36.7M
Cash$167.6M
Debt$43.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $122.9M

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Watertown, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $412.84 -1.13%
MRNA Moderna, Inc. $216.25 +1.17%
RVMD Revolution Medicines, Inc. $188.44 -2.84%
ROIV Roivant Sciences Ltd. $33.35 -3.58%
BNTX BioNTech SE Sponsored ADR $89.01 -7.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.